Dr Liz Dallimore on the exciting times ahead for Argenica Therapeutics as they fast track Phase 2
MAKING MONEY MATTER: Biotech companies have not been top of investors minds recently but I was excited to speak with Dr Liz Dallimore of Argenica Therapeutics (ASX:AGN) who are moving from Phase 1 to Phase 2 trials. Since we last spoke there has been a steady increase in the share price as they work on a drug to reduce brain damage after strokes as well as other brain injuries.TIME STAMPS:00:00 intro02:00 Background to Argenica Therapeutics (asx:AGN) and what sets them apart04:30 Phase 1 and Phase 2 trials and the outcomes from the trials06:50 The competition08:30 The recent placement and use of funds going forward12:00 The importance of the FDA approval and the market in the USA14:30 Timelines for the phase 2 trials and any challenges?18:00 Progress with the FDA21:00 Current valuation and milestones ahead and future partners23:30 The other applications for the company going forward26:30 Three reasons to sit up and take notice right now
- Forums
- ASX - By Stock
- AGN Media thread
Dr Liz Dallimore on the exciting times ahead for Argenica...
-
-
- There are more pages in this discussion • 199 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add AGN (ASX) to my watchlist
(20min delay)
|
|||||
Last
76.0¢ |
Change
0.020(2.70%) |
Mkt cap ! $97.35M |
Open | High | Low | Value | Volume |
73.5¢ | 76.0¢ | 72.3¢ | $96.97K | 130.3K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 3000 | 73.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
76.0¢ | 10000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 3000 | 0.735 |
1 | 4000 | 0.730 |
2 | 5130 | 0.720 |
1 | 7000 | 0.715 |
4 | 12210 | 0.700 |
Price($) | Vol. | No. |
---|---|---|
0.760 | 10000 | 1 |
0.765 | 10000 | 2 |
0.770 | 31660 | 2 |
0.800 | 15000 | 1 |
0.850 | 17000 | 3 |
Last trade - 15.40pm 27/09/2024 (20 minute delay) ? |
Featured News
AGN (ASX) Chart |